Company intelligence / Profile preview

SBI US Gateway Fund

Minato-ku, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

SBI US Gateway Fund is a venture capital fund managed by SBI Investment, the investment arm of the Japanese financial services conglomerate SBI Holdings. The fund specifically targets early-to-late-stage investment opportunities in the United States, with a significant focus on the biotechnology, life sciences, and healthcare sectors. By leveraging the global network of SBI Group, the fund aims to bridge innovative American startups with Asian markets, providing both capital and strategic cross-border support. Its portfolio includes a diverse range of companies working on novel therapeutics, medical devices, and digital health solutions.

Industry: Investors

Beyond the preview

Go deeper on SBI US Gateway Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBI US Gateway Fund.

Explore the full profile